Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Adenocarcinoma D000230 166 associated lipids
Agranulocytosis D000380 7 associated lipids
Albuminuria D000419 18 associated lipids
Alzheimer Disease D000544 76 associated lipids
Amnesia D000647 12 associated lipids
Anaphylaxis D000707 35 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Angina Pectoris D000787 27 associated lipids
Angina, Unstable D000789 14 associated lipids
Hypoxia D000860 23 associated lipids
Anthrax D000881 1 associated lipids
Arenaviridae Infections D001117 1 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Arteriosclerosis D001161 86 associated lipids
Arteriosclerosis Obliterans D001162 8 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Arthus Reaction D001183 8 associated lipids
Ascites D001201 25 associated lipids
Asphyxia Neonatorum D001238 4 associated lipids
Asthma D001249 52 associated lipids
Pulmonary Atelectasis D001261 1 associated lipids
Behcet Syndrome D001528 7 associated lipids
Birth Weight D001724 23 associated lipids
Blister D001768 16 associated lipids
Blood Platelet Disorders D001791 12 associated lipids
Body Weight D001835 333 associated lipids
Bovine Virus Diarrhea-Mucosal Disease D001912 2 associated lipids
Brain Diseases D001927 27 associated lipids
Brain Edema D001929 20 associated lipids
Brain Injuries D001930 4 associated lipids
Bronchial Diseases D001982 3 associated lipids
Bronchial Spasm D001986 18 associated lipids
Bronchiectasis D001987 7 associated lipids
Bronchopulmonary Dysplasia D001997 4 associated lipids
Bronchopulmonary Sequestration D001998 3 associated lipids
Burns D002056 34 associated lipids
Burns, Inhalation D002059 4 associated lipids
Carbon Monoxide Poisoning D002249 9 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Central Nervous System Diseases D002493 10 associated lipids
Brain Ischemia D002545 89 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Cerebrovascular Disorders D002561 25 associated lipids
Cholecystitis D002764 8 associated lipids
Cholestasis D002779 23 associated lipids
Cholestasis, Intrahepatic D002780 4 associated lipids
Chromoblastomycosis D002862 2 associated lipids
Cluster Headache D003027 4 associated lipids
Colitis D003092 69 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Colonic Diseases D003108 5 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Conjunctivitis D003231 7 associated lipids
Constriction, Pathologic D003251 8 associated lipids
Contracture D003286 3 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Coronary Disease D003327 70 associated lipids
Coronary Thrombosis D003328 7 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Cystitis D003556 23 associated lipids
Death, Sudden D003645 12 associated lipids
Dermatitis, Atopic D003876 19 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Diabetic Retinopathy D003930 39 associated lipids
Dictyocaulus Infections D004022 1 associated lipids
Disseminated Intravascular Coagulation D004211 7 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Duodenal Ulcer D004381 12 associated lipids
Dyslexia D004410 3 associated lipids
Ear Diseases D004427 7 associated lipids
Edema D004487 152 associated lipids
Encephalitis D004660 15 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Epilepsy D004827 35 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Escherichia coli Infections D004927 17 associated lipids
Extravasation of Diagnostic and Therapeutic Materials D005119 3 associated lipids
Fetal Growth Retardation D005317 9 associated lipids
Fever D005334 35 associated lipids
Fibrosis D005355 23 associated lipids
Gastritis D005756 27 associated lipids
Gastroesophageal Reflux D005764 10 associated lipids
Glioma D005910 112 associated lipids
Gliosis D005911 6 associated lipids
Glomerulonephritis D005921 35 associated lipids
Glomerulonephritis, IGA D005922 7 associated lipids
Rhinitis, Allergic, Seasonal D006255 7 associated lipids
Heart Arrest D006323 13 associated lipids
Heart Defects, Congenital D006330 20 associated lipids
Cardiomegaly D006332 31 associated lipids
Heart Injuries D006335 6 associated lipids
Hematoma, Subdural D006408 3 associated lipids
Hemolysis D006461 131 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Borin ML et al. [Relation between the changes in Na+/H+-exchange and cytoplasmic Ca levels in platelet activation]. 1988 Biull Eksp Biol Med pmid:2844320
Joseph R et al. Cytosolic ionized calcium homeostasis in platelets: an abnormal sensitivity to PAF-activation in migraine. 1988 Headache pmid:2844693
Michel L et al. Inhibitory effect of oral cetirizine on in vivo antigen-induced histamine and PAF-acether release and eosinophil recruitment in human skin. 1988 J. Allergy Clin. Immunol. pmid:2899102
Michel L et al. Release of PAF-acether and precursors during allergic cutaneous reactions. 1988 Lancet pmid:2899817
Frick KK et al. Platelet-derived growth factor-induced c-myc RNA expression. Analysis of an inducible pathway independent of protein kinase C. 1988 J. Biol. Chem. pmid:2449430
Dillon PK and Durán WN Effect of platelet-activating factor on microvascular permselectivity: dose-response relations and pathways of action in the hamster cheek pouch microcirculation. 1988 Circ. Res. pmid:2450695
Okuda Y et al. Histamine release from human leukocytes by platelet-activating factor. 1988 Int. Arch. Allergy Appl. Immunol. pmid:2450844
Spicer BA et al. Changes in leucocyte numbers without diapedesis in rats given platelet-activating factor (PAF-acether). 1988 Int. Arch. Allergy Appl. Immunol. pmid:2450847
Bachelet M et al. Interaction between PAF-acether and drugs that stimulate cyclic AMP in guinea-pig alveolar macrophages. 1988 Eur. J. Pharmacol. pmid:2840303
Lerner R et al. Platelet activating factor and leukotriene B4 induce hyperpolarization of human endothelial cells but depolarization of neutrophils. 1988 Biochem. Biophys. Res. Commun. pmid:2838025
Trovati M et al. Insulin directly reduces platelet sensitivity to aggregating agents. Studies in vitro and in vivo. 1988 Diabetes pmid:2838353
Slapke J et al. [Test hierarchy for the development of new drug action principles with the action site in phospholipid metabolism for bronchial asthma and pulmonary hypertension]. 1988 Prax Klin Pneumol pmid:3140230
Lefort J et al. Pharmacological profile of 48740 R.P., a PAF-acether antagonist. 1988 Eur. J. Pharmacol. pmid:2843382
Kuiper J et al. The induction of glycogenolysis in the perfused liver by platelet activating factor is mediated by prostaglandin D2 from Kupffer cells. 1988 Biochem. Biophys. Res. Commun. pmid:3144970
Valone FH and Epstein LB Biphasic platelet-activating factor synthesis by human monocytes stimulated with IL-1-beta, tumor necrosis factor, or IFN-gamma. 1988 J. Immunol. pmid:3141509
Bratton DL et al. Effects of platelet activating factor and related lipids on phase transition of dipalmitoylphosphatidylcholine. 1988 Biochim. Biophys. Acta pmid:3370214
Wang J et al. The effects of endotoxin on platelet-activating factor synthesis in cultured rat glomerular mesangial cells. 1988 Biochim. Biophys. Acta pmid:3370222
Grue-Sørensen G et al. Derivatives of 2-methylenepropane-1,3-diol as new antagonists of platelet activating factor. 1988 J. Med. Chem. pmid:3373485
Pirotzky E et al. Protection of platelet-activating factor-induced acute renal failure by BN 52021. 1988 Br J Exp Pathol pmid:3377967
Csatò M and Czarnetzki BM Effect of BN 52021, a platelet activating factor antagonist, on experimental murine contact dermatitis. 1988 Br. J. Dermatol. pmid:3377969
O'Flaherty JT et al. Mechanism involved in the mobilization of neutrophil calcium by 5-hydroxyeicosatetraenoate. 1988 J. Immunol. pmid:2836511
Hoffman DR et al. Platelet-activating factor induces glycogen degradation in fetal rabbit lung in utero. 1988 J. Biol. Chem. pmid:3379072
Kertscher HP et al. [Synthesis and thrombocyte-aggregating action of a structural analog of platelet activating factor with a modified head group]. 1988 Pharmazie pmid:3380866
Smith RJ et al. Diacylglycerols modulate human polymorphonuclear neutrophil responsiveness: effects on intracellular calcium mobilization, granule exocytosis, and superoxide anion production. 1988 J. Leukoc. Biol. pmid:2836539
Achterrath-Tuckermann U et al. Azelastine, a new antiallergic/antiasthmatic agent, inhibits PAF-acether-induced platelet aggregation, paw edema and bronchoconstriction. 1988 Pharmacology pmid:3380879
Kornecki E and Ehrlich YH Neuroregulatory and neuropathological actions of the ether-phospholipid platelet-activating factor. 1988 Science pmid:3381103
Lichterfeld A et al. [Platelet activating factor and its possible role in bronchial asthma]. 1988 Prax Klin Pneumol pmid:3041401
Barnes PJ Inflammatory mechanisms and nocturnal asthma. 1988 Am. J. Med. pmid:3041827
Serio R and Daniel EE Thromboxane effects on canine trachealis neuromuscular function. 1988 J. Appl. Physiol. pmid:2839451
Kok PT et al. Arachidonic acid can induce leukotriene C4 formation by purified human eosinophils in the absence of other stimuli. 1988 Biochem. Biophys. Res. Commun. pmid:3132917
Tomooka M et al. [Azelastine inhibits bronchoconstriction induced by histamine and leukotriene C4]. 1988 Arerugi pmid:2906534
Iwama T et al. Pharmacological modulation of platelet activating factor (PAF)-induced bronchoconstriction and hypertension in anaesthetized guinea-pigs. 1988 J. Pharm. Pharmacol. pmid:2907007
Nogami M et al. [Effects of a PAF antagonist CV-3988 on the acute gastric erosions of rats by water-immersion stress]. 1988 Nihon Shokakibyo Gakkai Zasshi pmid:3404759
Biologically active ether lipids. 1988 Prog Biochem Pharmacol pmid:3405995
Taira M et al. Lack of involvement of leukotriene and platelet activating factor in passive cutaneous anaphylaxis in rats. 1988 Agents Actions pmid:3407549
Mollinedo F et al. Intracellular localization of platelet-activating factor synthesis in human neutrophils. 1988 Biochem. Biophys. Res. Commun. pmid:3408495
Koenderman L et al. An improved method for the isolation of eosinophilic granulocytes from peripheral blood of normal individuals. 1988 J. Leukoc. Biol. pmid:3404069
Hirafuji M et al. Transient increase of cytosolic free calcium in cultured human vascular endothelial cells by platelet-activating factor. 1988 Biochem. Biophys. Res. Commun. pmid:3408504
Anderson GP and Fennessy MR Lipoxygenase metabolites as mediators of platelet activating factor-induced increased airways responsiveness to histamine in the guinea-pig. 1988 Agents Actions Suppl. pmid:3140616
Stahl GL et al. Salutary consequences of blockade of platelet activating factor in hemorrhagic shock. 1988 Eur. J. Pharmacol. pmid:3409951
Coyle AJ et al. The effect of the selective PAF antagonist BN 52021 on PAF- and antigen-induced bronchial hyper-reactivity and eosinophil accumulation. 1988 Eur. J. Pharmacol. pmid:3383997
Kroegel C et al. Platelet-activating factor induces eosinophil peroxidase release from purified human eosinophils. 1988 Immunology pmid:3410498
Tokumura A et al. Study of platelet activating factor and its antagonists on rat colon strip with a new method avoiding tachyphylaxis. 1988 Eur. J. Pharmacol. pmid:3384001
Takizawa H et al. Bronchoconstriction induced by platelet-activating factor in the guinea pig and its inhibition by CV-3988, a PAF antagonist: serial changes in findings of lung histology and bronchoalveolar lavage cell population. 1988 Int. Arch. Allergy Appl. Immunol. pmid:3410557
Misawa M and Takata T Effects of platelet-activating factor on rat airways. 1988 Jpn. J. Pharmacol. pmid:3199608
Kato T et al. Augmentation of DNA synthesis in guinea pig bone marrow cells by platelet-activating factor (PAF). 1988 Biochem. Biophys. Res. Commun. pmid:3202869
Roberts NM et al. Effect of a PAF antagonist, BN52063, on PAF-induced bronchoconstriction in normal subjects. 1988 Br J Clin Pharmacol pmid:3203062
Freitas JC et al. Inhibition of platelet aggregation by manoalide: preliminary results. 1988 Braz. J. Med. Biol. Res. pmid:3203166
Collier M et al. Biochemical and pharmacological characterization of human embryo-derived platelet activating factor. 1988 Hum. Reprod. pmid:3204154
Ohmori K et al. Antiinflammatory and antiallergic effects of a novel metabolite of Nocardiopsis sp. as a potent protein kinase C inhibitor from microbial origin. 1988 Arzneimittelforschung pmid:2972291
Masugi F et al. Platelet-activating factor and anti-platelet-aggregating factor in acute reduction of blood pressure following percutaneous transluminal renal angioplasty in patients with renovascular hypertension. 1988 J Hum Hypertens pmid:2977405
Bussolino F et al. Platelet activating factor induces dopamine release in PC-12 cell line. 1988 Am. J. Physiol. pmid:3177629
Gay JC and Stitt ES Platelet-activating factor induces protein kinase activity in the particulate fraction of human neutrophils. 1988 Blood pmid:2825844
Hill CE et al. Location of platelet activating factor binding in rat liver. 1988 Biochem. J. pmid:3178735
Crouch MF and Lapetina EG Spacial isolation of protein kinase C activation in thrombin stimulated human platelets. 1988 Biochem. Biophys. Res. Commun. pmid:3178827
Andersson M and Pipkorn U The effect of platelet activating factor on nasal hypersensitivity. 1988 Eur. J. Clin. Pharmacol. pmid:3181276
Adamus WS et al. Inhibitory effect of oral WEB 2086, a novel selective PAF-acether antagonist, on ex vivo platelet aggregation. 1988 Eur. J. Clin. Pharmacol. pmid:3181277
Yanoshita R et al. Hydrolysis of platelet activating factor and its methylated analogs by acetylhydrolases. 1988 J. Biochem. pmid:3182751
Lakin KM [Problems of a pharmacologic search for inhibitors of platelet aggregation]. 1988 Kardiologiia pmid:3066962
Kawaguchi H et al. [Effect of platelet-activating factor (PAF) on blood pressure, peripheral, coronary and renovascular system]. 1988 Kokyu To Junkan pmid:3067285
Kumar R et al. Occurrence of platelet-activating factor in rabbit spermatozoa. 1988 Arch. Biochem. Biophys. pmid:3341753
Huo YN et al. A preferential inhibition by Zn2+ on platelet activating factor- and thrombin-induced serotonin secretion from washed rabbit platelets. 1988 Arch. Biochem. Biophys. pmid:3341767
Whatley RE et al. The regulation of synthesis of platelet-activating factor by endothelial cells. 1988 Chest pmid:3342689
Ukena D et al. Radioligand binding of antagonists of platelet-activating factor to intact human platelets. 1988 FEBS Lett. pmid:3342883
Suzuki Y et al. Release of acetylhydrolase from platelets on aggregation with platelet-activating factor. 1988 Eur. J. Biochem. pmid:3345757
Benveniste J and Leyravaud S Retention of platelet activating factor by human neutrophils. 1988 J. Immunol. pmid:3346547
Immunomodulation: other approaches. 1988 Transplant. Proc. pmid:3347955
Lang CH et al. Platelet-activating factor-induced increases in glucose kinetics. 1988 Am. J. Physiol. pmid:3348371
Molski TF et al. Intracellular calcium rise produced by platelet-activating factor is deactivated by fMet-Leu-Phe and this requires uninterrupted activation sequence: role of protein kinase C. 1988 Biochem. Biophys. Res. Commun. pmid:3348814
Rees RS et al. Plasma components are required for platelet activation by the toxin of Loxosceles reclusa. 1988 Toxicon pmid:3245050
Tatsumi N et al. Neutrophil chemiluminescence induced by platelet activating factor and suppressed by C-reactive protein. 1988 Clin. Chim. Acta pmid:3359655
Mencia-Huerta JM et al. [Effect of long-term administration of platelet activating factor on pulmonary response and morphology in the guinea pig]. 1988 Allerg Immunol (Paris) pmid:3245884
Hsueh W et al. Sequential release of leukotrienes and norepinephrine in rat bowel after platelet-activating factor. A mechanistic study of platelet-activating factor-induced bowel necrosis. 1988 Gastroenterology pmid:3360262
Hasegawa T and Nakajima S [Recent topics on platelet-activating-factor (PAF)]. 1988 Nippon Ika Daigaku Zasshi pmid:3360909
Touvay C et al. Role of platelet-activating factor (PAF) in the bronchopulmonary alterations and beta-adrenoceptor function induced by endotoxin. 1988 Biochem. Biophys. Res. Commun. pmid:2835036
Kimani G et al. Stimulation of eosinophil adherence to human vascular endothelial cells in vitro by platelet-activating factor. 1988 J. Immunol. pmid:3361129
Robertson DA et al. Negative inotropic effect of platelet-activating factor: association with a decrease in intracellular sodium activity. 1988 J. Pharmacol. Exp. Ther. pmid:3361438
17th annual UCLA symposium. Abstracts: Cell activation and signal initiation: receptor and phospholipase control of inositol phosphate, PAF and eicosanoid production. 1988 J. Cell. Biochem. Suppl. pmid:2835556
Paulson SK and Nicholson NS A radioreceptor binding assay for measurement of platelet-activating factor synthesis by human neutrophils. 1988 J. Immunol. Methods pmid:2837517
Eliakim R et al. Role of platelet-activating factor in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine and prednisolone. 1988 Gastroenterology pmid:2901995
Ng DS and Wong K Specific binding of platelet-activating factor (PAF) by human peripheral blood mononuclear leukocytes. 1988 Biochem. Biophys. Res. Commun. pmid:2843182
Browne PC et al. Kinetics of the formation of thrombin-thrombospondin complexes: involvement of a 77-kDa intermediate. 1988 Arch. Biochem. Biophys. pmid:2844122
Royall JA and Levin DL Adult respiratory distress syndrome in pediatric patients. I. Clinical aspects, pathophysiology, pathology, and mechanisms of lung injury. 1988 J. Pediatr. pmid:3276861
Vanhoutte PM Platelets, endothelium and blood vessel wall. 1988 Experientia pmid:3278917
Lellouch-Tubiana A et al. Eosinophil recruitment into guinea pig lungs after PAF-acether and allergen administration. Modulation by prostacyclin, platelet depletion, and selective antagonists. 1988 Am. Rev. Respir. Dis. pmid:3281530
Chung KF and Barnes PJ PAF antagonists. Their potential therapeutic role in asthma. 1988 Drugs pmid:3281823
Plante GE et al. Platelet activating factor antagonism with BN52021 protects the kidney against acute ischemic injury. 1988 Prostaglandins Leukot. Essent. Fatty Acids pmid:3231663
Santos JC et al. Effect of intrarenal infusion of synthetic PAF-acether in dogs. 1988 Rev. Esp. Fisiol. pmid:3231880
Ostermann G et al. The degradation of platelet-activating factor in serum and its discriminative value in atherosclerotic patients. 1988 Thromb. Res. pmid:3232123
Avdonin PV et al. Blocking of the receptor-stimulated calcium entry into human platelets by verapamil and nicardipine. 1988 Thromb. Res. pmid:3232128
Aratani H et al. Effect of etizolam (Depas) on production of superoxide anion by platelet-activating factor and N-formyl-methionyl-leucyl-phenylalanine-stimulated guinea pig polymorphonuclear leukocytes. 1988 Jpn. J. Pharmacol. pmid:2848961
Robertson DN et al. The effect of platelet-activating factor on histamine and muscarinic receptor function in guinea pig airways. 1988 Am. Rev. Respir. Dis. pmid:2849329
Stewart AG and Dusting GJ Characterization of receptors for platelet-activating factor on platelets, polymorphonuclear leukocytes and macrophages. 1988 Br. J. Pharmacol. pmid:2850058
Korth R et al. Comparison of three paf-acether receptor antagonist ginkgolides. 1988 Eur. J. Pharmacol. pmid:2850196
Valone FH Interrelationships among platelet-activating factor binding and metabolism and induction of platelet activation. 1988 Prog. Clin. Biol. Res. pmid:2850575
Shukla SD and Morrison WJ Platelet activating factor receptor occupancy in relation to activation and desensitization of phosphoinositide specific phospholipase C. 1988 Prog. Clin. Biol. Res. pmid:2850576
Chand N et al. Effect of paf-acether on isoprenaline-induced relaxation in isolated tracheal segments of rats and guinea pigs. 1988 Eur. J. Pharmacol. pmid:2851453
Hayashi H et al. A novel bioaction of PAF: induction of microbicidal activity in guinea pig bone marrow cells. 1988 Lipids pmid:2852289
Janero DR et al. Radioligand competitive binding methodology for the evaluation of platelet-activating factor (PAF) and PAF-receptor antagonism using intact canine platelets. 1988 J Pharmacol Methods pmid:2853256
White HL and Faison LD Inhibition of lyso-PAF: acetyl-CoA acetyltransferase by salicylates and other compounds. 1988 Prostaglandins pmid:2903520